David Laharie

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

David Laharie, Arnaud Bourreille, Julien Branche et al. · The Lancet · 2012 · 642 citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Édouard Louis, Jean‐Yves Mary, Gwénola Vernier-Massouille et al. · Gastroenterology · 2011 · 593 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Philippe Marteau, Marc Lémann, Philippe Seksik et al. · Gut · 2005 · 411 citations · Full text

Life Sciences, Immunology, Surgery +16

Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations

Juliette Foucher, Laurent Cast ra, Pierre–Henri Bernard et al. · European Journal of Gastroenterology & Hepatology · 2006 · 379 citations

Medicine, Internal Medicine, Diagnostic Imaging +13

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

Marc Lémann, Jean–Yves Mary, Bernard Duclos et al. · Gastroenterology · 2006 · 372 citations

Pharmacy, Immunology, Pharmacotherapy +12